Yue Zhao

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 17

Top Venues

EMBO molecular medicine

Cell death & disease

Cancer science

Cell death and differentiation

China Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Medical University Aug 16 2008

China

Professor :: School of Life Sciences

Publications

Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine 16 (1) (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine 16 (1) (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine 16 (1) (2023)
Kai Zeng, Weiwen Xie, Chunyu Wang, Shengli Wang, Wei Liu, Yingjie Su, Lin Lin, Renlong Zou, Ge Sun, Baosheng Zhou, Manlin Wang, Ruina Luan, Yu Bai, Yunlong Huo, Shigeaki Kato, Xinping Zhong, Yue Zhao
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma. Cell death & disease 14 (3) (2023)
Kai Zeng, Weiwen Xie, Chunyu Wang, Shengli Wang, Wei Liu, Yingjie Su, Lin Lin, Renlong Zou, Ge Sun, Baosheng Zhou, Manlin Wang, Ruina Luan, Yu Bai, Yunlong Huo, Shigeaki Kato, Xinping Zhong, Yue Zhao
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma. Cell death & disease 14 (3) (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine 16 (1) (2023)
Kai Zeng, Weiwen Xie, Chunyu Wang, Shengli Wang, Wei Liu, Yingjie Su, Lin Lin, Renlong Zou, Ge Sun, Baosheng Zhou, Manlin Wang, Ruina Luan, Yu Bai, Yunlong Huo, Shigeaki Kato, Xinping Zhong, Yue Zhao
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma. Cell death & disease 14 (3) (2023)
Kai Zeng, Weiwen Xie, Chunyu Wang, Shengli Wang, Wei Liu, Yingjie Su, Lin Lin, Renlong Zou, Ge Sun, Baosheng Zhou, Manlin Wang, Ruina Luan, Yu Bai, Yunlong Huo, Shigeaki Kato, Xinping Zhong, Yue Zhao
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma. Cell death & disease 14 (3) (2023)
Ge Sun, Yuntao Wei, Baosheng Zhou, Manlin Wang, Ruina Luan, Yu Bai, Hao Li, Shan Wang, Dantong Zheng, Chunyu Wang, Shengli Wang, Kai Zeng, Shuchang Liu, Lin Lin, Mingcong He, Qiang Zhang, Yue Zhao
BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer. Cell death and differentiation (2023)
Tingting Zhou, Shengli Wang, Xiao-Yu Song, Wensu Liu, Fang Dong, Yunlong Huo, Renlong Zou, Chunyu Wang, Siyi Zhang, Wei Liu, Ge Sun, Lin Lin, Kai Zeng, Xiang Dong, Qiqiang Guo, Fei Yi, Zhuo Wang, Xiaoman Li, Bo Jiang, Liu Cao, Yue Zhao
RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression. Cell death & disease 13 (4) (2022)
Shan Wei, Wei Liu, Ning Sun, Yi Wu, Huijuan Song, Chunyu Wang, Shengli Wang, Renlong Zou, Lin Lin, Kai Zeng, Baosheng Zhou, Manlin Wang, Ruina Luan, Fan Yang, Yue Zhao
MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma. Cancer science 112 (5) (2021)
Chi Lv, Shengli Wang, Lin Lin, Chunyu Wang, Kai Zeng, Yiming Meng, Ge Sun, Shan Wei, Yefu Liu, Yue Zhao
USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma. Cell death & disease 12 (9) (2021)
Shengli Wang, Xinping Zhong, Chunyu Wang, Hao Luo, Lin Lin, Hongmiao Sun, Ge Sun, Kai Zeng, Renlong Zou, Wei Liu, Ning Sun, Huijuan Song, Wensu Liu, Qiang Zhang, Zhixuan Liao, Xiaochun Teng, Tingting Zhou, Xun Sun, Yue Zhao
USP22 positively modulates ERα action via its deubiquitinase activity in breast cancer. Cell death and differentiation 27 (11) (2020)
Huijuan Song, Ning Sun, Lin Lin, Shan Wei, Kai Zeng, Wei Liu, Chunyu Wang, Xinping Zhong, Manlin Wang, Shengli Wang, Baosheng Zhou, Chi Lv, Wensu Liu, Yue Zhao
Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma. Cancer science 111 (10) (2020)
Kai Zeng, Yi Wu, Chunyu Wang, Shengli Wang, Hongmiao Sun, Renlong Zou, Ge Sun, Huijuan Song, Wei Liu, Ning Sun, Shan Wei, Wensu Liu, Yingjie Su, Tingting Zhou, Yi Zhang, Yue Zhao
ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription. Cancer science 111 (6) (2020)

Yue Zhao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yue Zhao